The purpose of this study is to evaluate the clinical outcomes of Cytomegalovirus (CMV) virus in the participants' body. Therefore, the study team will follow the participants' immunological response based on the Cytomegalovirus (CMV) virus testing.
Adult patients over 18 years of age
Lung transplant candidates with positive CMV IgG
Anticipated to receive a lung transplant (both double lung and single lung)
Negative CMV IgG prior transplant
Pregnant or breastfeeding women
HIV infected patients
Combined organ (e.g., lung-heart, lung-kidney) transplant candidates
University of Miami
Lead sponsor
Eurofins Viracor
Collaborator